Plante Moran Financial Advisors’s Accelerate Diagnostics AXDX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
-100
| Closed | -$70 | – | 777 |
|
|
2025
Q1 | $70 | Hold |
100
| – | – | ﹤0.01% | 783 |
|
|
2024
Q4 | $120 | Hold |
100
| – | – | ﹤0.01% | 890 |
|
|
2024
Q3 | $171 | Hold |
100
| – | – | ﹤0.01% | 855 |
|
|
2024
Q2 | $117 | Hold |
100
| – | – | ﹤0.01% | 763 |
|
|
2024
Q1 | $99 | Hold |
100
| – | – | ﹤0.01% | 829 |
|
|
2023
Q4 | $392 | Hold |
100
| – | – | ﹤0.01% | 778 |
|
|
2023
Q3 | $575 | Hold |
100
| – | – | ﹤0.01% | 707 |
|
|
2023
Q2 | $810 | Hold |
100
| – | – | ﹤0.01% | 743 |
|
|
2023
Q1 | $700 | Hold |
100
| – | – | ﹤0.01% | 745 |
|
|
2022
Q4 | $706 | Hold |
100
| – | – | ﹤0.01% | 779 |
|
|
2022
Q3 | $2K | Hold |
100
| – | – | ﹤0.01% | 773 |
|
|
2022
Q2 | $1K | Hold |
100
| – | – | ﹤0.01% | 877 |
|
|
2022
Q1 | $1K | Hold |
100
| – | – | ﹤0.01% | 764 |
|
|
2021
Q4 | $5K | Hold |
100
| – | – | ﹤0.01% | 807 |
|
|
2021
Q3 | $6K | Hold |
100
| – | – | ﹤0.01% | 753 |
|
|
2021
Q2 | $8K | Hold |
100
| – | – | ﹤0.01% | 705 |
|
|
2021
Q1 | $8K | Hold |
100
| – | – | ﹤0.01% | 682 |
|
|
2020
Q4 | $8K | Hold |
100
| – | – | ﹤0.01% | 647 |
|
|
2020
Q3 | $11K | Hold |
100
| – | – | ﹤0.01% | 586 |
|
|
2020
Q2 | $15K | Hold |
100
| – | – | 0.01% | 474 |
|
|
2020
Q1 | $8K | Hold |
100
| – | – | ﹤0.01% | 516 |
|
|
2019
Q4 | $17K | Sell |
100
-300
| -75% | -$49.5K | 0.01% | 480 |
|
|
2019
Q3 | $74K | Hold |
400
| – | – | 0.02% | 280 |
|
|
2019
Q2 | $92K | Hold |
400
| – | – | 0.03% | 231 |
|
|
2019
Q1 | $84K | Hold |
400
| – | – | 0.03% | 239 |
|
|
2018
Q4 | $46K | Hold |
400
| – | – | 0.02% | 302 |
|
|
2018
Q3 | $92K | Hold |
400
| – | – | 0.03% | 223 |
|
|
2018
Q2 | $89K | Hold |
400
| – | – | 0.05% | 237 |
|
|
2018
Q1 | $91K | Hold |
400
| – | – | 0.05% | 247 |
|
|
2017
Q4 | $105K | Hold |
400
| – | – | 0.06% | 212 |
|
|
2017
Q3 | $90K | Buy |
400
+100
| +33% | +$24.6K | 0.05% | 216 |
|
|
2017
Q2 | $82K | Buy |
300
+100
| +50% | +$27.1K | 0.05% | 238 |
|
|
2017
Q1 | $48K | Buy |
+200
| New | +$45.7K | 0.03% | 325 |
|
Other funds holding AXDX
Plante Moran Financial Advisors's AXDX Position: Q2 2025 in Review
Plante Moran Financial Advisors sold out of Accelerate Diagnostics (AXDX) in Q2 2025, closing a stake of 100 shares — an estimated $70 sold.
Plante Moran Financial Advisors first reported a position in AXDX in Q1 2017 and held it in 33 quarters. The position peaked at $105K in Q4 2017. 3 funds tracked by Wall St. Rank hold AXDX as of Q2 2025.
- Plante Moran Financial Advisors reported no remaining Accelerate Diagnostics position as of Q2 2025 after selling out during the quarter.
- Plante Moran Financial Advisors sold 100 Accelerate Diagnostics shares in Q2 2025, an estimated $70.
- Plante Moran Financial Advisors first reported a position in Accelerate Diagnostics in Q1 2017 and held it in 33 quarters.
- Plante Moran Financial Advisors's Accelerate Diagnostics position peaked at $105K in Q4 2017.
- 3 funds tracked by Wall St. Rank held Accelerate Diagnostics as of Q2 2025.
Based on Plante Moran Financial Advisors's 13F filing for Q2 2025, filed 5 Aug 2025.